• Jeff Samberg

    Mr. Samberg is the Managing Member of Acadia Woods Partners, LLC, a New York-based investment partnership that focuses primarily on early-stage technology companies. He lived in the San Francisco Bay area for 15 years where he held a number of high-technology management roles, including Vice President of Corporate Strategy for PeopleSoft Inc., Vice President of Business Development for Wily Technology, and Entrepreneur in Residence for Greylock Partners. Mr. Samberg received a B.A. with high honors in economics from Princeton University and MBA from Stanford University’s Graduate School of Business.

    Mederi Therapeutics Inc.
  • Bob Knarr


    Mr. Knarr joined Mederi as CEO on October 1, 2015. A specialist in medical device growth and development, Mr. Knarr was part of the executive team at US Surgical that drove revenue growth from less than $10 million to more than $1.5 billion. His roles at USSC grew from 1977, as a sales representative, to 1998 as President of North American Operations, he also served as a member of the Board of Directors of USSC. He most recently was a founding partner of JHK investments, a medical device focused venture capital firm led by the founders of US Surgical. Their portfolio of products and companies included interventional cardiology (Angiolink, Jarvik Heart, Interventional Therapies), Cryogen, Biowave pain management products, and Vivatone Hearing Aid Systems.

    Mederi Therapeutics Inc.
  • William W. Rutan


    Mr. Rutan served as the Chief Executive of Mederi Therapeutics from 2009 to October 1, 2015. He has over 30 years of experience in the medical device industry, including 15 years with United States Surgical Corporation where he was Corporate Vice President. Mr. Rutan spent several years as an entrepreneur in residence with JHK Investments, a medical device focused venture capital firm led by the founders of US Surgical. Mr. Rutan’s responsibilities at JHK included executive management roles at CryoGen Inc and Vascular Therapies, where successful exits were made to AMS (Cryogen) and Medtronic (Angiolink). His most recent role prior to Mederi was as CEO of MiniLap Technologies, whose products are now owned by Telefex. 

    Mederi Therapeutics Inc.
Mederi Therapeutics » The Mederi Team » Board of Directors